Jaguar動物健康 JAGX 深 滬
已收盤 08-01 16:00:00 美东时间
1.98
-0.060
-2.94%
華盛通- 最 高2.01
- 今 開2.00
- 成交量 4.12万股
- 最 低 1.9301
- 昨 收 2.04
- 總市值 250.41万
- 52周最高 35.25
- 市盈率 靜 --
- 換手率 3.26%
- 52周最低 1.9301
- 委 比 -43.00%
- 總股本 126.47万
- 歷史最高 2501887500.00
- 量 比 0.55
- 振 幅 3.92%
- 歷史最低 1.9301
- 每 手 1
- 風險率 10.68%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares rose 239.4% to $17.55 dur...
07-14 20:08
Jaguar Animal Health Issues Series M Preferred Stock
Jaguar Animal Health ( ($JAGX) ) has provided an announcement. On June 27, 2025...
07-01 03:49
Jaguar Health's Napo Announces That Initial Proof-Of-Concept Results From Ongoing IIT Show Liquid Formulation Of Crofelemer Reduced Required TPN And Supplementary Intravenous Fluids In Third Intestinal Failure Patient
As recently announced, initial proof-of-concept results from this ongoing investigator-initiated trial (IIT) show crofelemer reduced the required total parenteral nutrition in the first participating microvillus
06-30 21:23
Jaguar Health Updates On Orphan Disease Intestinal Failure Program; Completion Of Napo's Phase 2 Study Of Crofelemer In Pediatric MVID Patients Is Expected In Mid-2026 As Planned
Enrollment in company's first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for microvillus inclusion disease (MVID) in pediatric patients has reached approximately 25%As recently
06-23 21:07
Jaguar Health's Napo Pharma Advances Crofelemer For Cancer Therapy-Related Diarrhea Following FDA Type C Meeting
Productive and collaborative discussion on proposed pathway by the company to bring crofelemer to approval for cancer therapy-related diarrhea (CTD) in patients with metastatic breast cancer receiving selected targeted
06-09 21:05
Jaguar Health Announces $1.5M Direct Stock Offering
Jaguar Animal Health ( ($JAGX) ) has shared an update. On May 20, 2025, Jaguar ...
05-22 18:48
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Biodesix (NASDAQ:BDSX) shares increased by 72.6% to $0.47 during Wedne...
05-22 01:06
美股大行评级 | 摩根大通：维持网易"超配"评级，目标价升至135美元；瑞银上调达美航空评级至"买入"
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1131517965561573377.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Armata Pharmaceuticals(ARMP)"买入"评级，目标价从7美元升至9美元</p> <p>• 瑞银：维持爱芬奇(ANF)"买入"评级，目标价从115美
05-20 09:28
First Berlin Initiates Coverage On Jaguar Health with Buy Rating, Announces Price Target of $60
First Berlin analyst Christian Orquera initiates coverage on Jaguar Health (NASDAQ:JAGX) with a Buy rating and announces Price Target of $60.
05-19 23:24
Jaguar Animal Health Executes Stock Exchange Agreements
An announcement from Jaguar Animal Health ( ($JAGX) ) is now available. On May ...
05-16 04:19
